These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antiviral agents in the treatment of chronic viral hepatitis. Perrillo RP. Prog Liver Dis; 1992 Dec; 10():283-309. PubMed ID: 1284255 [No Abstract] [Full Text] [Related]
4. [Interferon therapy in chronic active viral hepatitis]. Lengyel G, Fehér J. Orv Hetil; 1995 Jan 01; 136(1):3-7. PubMed ID: 7531317 [Abstract] [Full Text] [Related]
7. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2. Stancek D, Fuchsberger N, Oltman M, Schmeisser H, Kontsek P, Jahnová E, Hajnická V. Acta Virol; 2001 Jan 01; 45(5-6):287-92. PubMed ID: 12083327 [Abstract] [Full Text] [Related]
8. [Treatment of chronic viral hepatitis with recombinant interferon-alfa]. Peter F. Orv Hetil; 1992 Jul 05; 133 Suppl 1():66-71. PubMed ID: 1630806 [Abstract] [Full Text] [Related]
16. Antiviral therapy in HBsAg-positive chronic liver disease (HBsAg+ve CLD): how many patients really need it? Ascione A, Amitrano L, Riccio E, De Lella A, Canestrini C, de Bellis G, D'Alessandro R, Fiore R, Padulano P. Hepatogastroenterology; 1984 Jun 05; 31(3):123-4. PubMed ID: 6469200 [Abstract] [Full Text] [Related]